Chromosome microdissection identifies genomic amplifications associated with drug resistance in a leukemia cell line: an approach to understanding drug resistance in cancer.

Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology
Frouzandeh MahjoubiGreg B Peters

Abstract

A significant problem encountered in the treatment of cancer patients is that cancer cells often evolve resistance to chemotherapeutic agents. One of the mechanisms responsible for drug resistance is gene amplification. The study of the behavior of genes conferring drug resistance is very important to determine future treatments for cancer patients that will minimize the effect of gene amplification. One of the best methods to investigate this phenomenon is to use chromosome microdissection to directly access the amplified gene or genes. In the present study, chromosome microdissection and fluorescent in-situ hybridization (FISH) were applied for the identification of genes residing in a homogeneously staining region (HSR) in drug-resistant cell sublines developed by treatment of the T-cell leukemia cell line CCRF-CEM with increasing levels of the anthracycline, epirubicin. We have demonstrated that the selection by epirubicin actually elevated the level of the multidrug resistance-associated protein (MRP1) gene. We argue that the breakage fusion bridge (B-F-B) cycle offers a plausible explanation for this amplification. The DNA prepared from the amplified regions by chromosome microdissection provides a resource for future inv...Continue Reading

References

Dec 8, 1978·Science·R T SchimkeR F Kellems
Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·K A SmithG R Stark
Mar 3, 1995·International Journal of Cancer. Journal International Du Cancer·E W EijdemsF Baas
Jan 1, 1994·Leukemia & Lymphoma·D C ZhouJ P Marie
Jan 1, 1993·Advances in Cancer Research·G R Stark
Sep 29, 1999·Advances in Experimental Medicine and Biology·M FilipitsR Pirker
Sep 29, 1999·Advances in Experimental Medicine and Biology·T KöhlerH Remke
Oct 31, 2002·Neoplasia : an International Journal for Oncology Research·Anthony W I LoJohn P Murnane

❮ Previous
Next ❯

Citations

Mar 14, 2007·Archives of Medical Research·Masoud GolalipourAlimoghaddam Kamran
Apr 2, 2009·Medical and Veterinary Entomology·M R D BatistaL B Klaczko
Feb 15, 2011·Genes, Chromosomes & Cancer·Kunio KitadaSatoko Aikawa
Oct 16, 2008·BioTechniques·Emanuela V Volpi, Joanna M Bridger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.